TABLE 1.
Clinical Characteristics
| Characteristic | Total (N = 52) | HP-Positive (n = 19) | HP-Negative (n = 33) |
|---|---|---|---|
| Age, years | |||
| Median (range) | 68 (52-87) | 68 | 67 |
| Sex, No. (%) | |||
| Male | 29 (55.8) | 11 (57.9) | 18 (54.5) |
| Female | 23 (44.2) | 8 (42.1) | 15 (45.5) |
| Methods for detecting HP infection, No. (%) | |||
| Tissue immunostaining | 51 (98) | 14 (73.6) | 33 (100) |
| Serum antibody (serology) | 19 (36.5) | 3 (15.8) | 16 (48.4) |
| Stool antigen | 10 (19.2) | 1 (5.3) | 9 (27.2) |
| Urea breath test | 6 (11.5) | 1 (5.3) | 5 (15.1) |
| PCR or FISH for t(11;18), No. (%) | |||
| Detected | 2 (3.8) | 0 (0.0) | 2 (6.1) |
| Not detected | 8 (15.4) | 2 (10.5) | 6 (18.2) |
| Unknown | 42 (80.8) | 17 (89.5) | 25 (75.7) |
| HP eradication therapy, No. (%) | 27 (51.9) | 19 (100) | 8 (24.2) |
Abbreviations: FISH, fluorescent in situ hybridization; HP, Helicobacter pylori; PCR, polymerase chain reaction.